Table 5 Predictive value of each status

Duration of MTX (month)

50 (7–172)

81 (40–234)

0.19

Dose of MTX (mg/week)

8.0 (4.0–16.0)

9.0 (6.0–16.0)

0.14

Number of sites

5 (1–99)

3 (1–41)

0.30

SUVmax

9.2 (2.8–47.1)

13.9 (0–24.9)

0.21

WBMTV (ml)

26.6 (0–362.6)

22.7 (0–250.1)

0.36

WBTLG (ml)

111.6 (0–2180.9)

152.1 (0–1052.1)

0.25

sIL-2R (U/ml)

758 (310–3157)

795 (259–5861)

0.16